Published in Gut on June 01, 1965
ABO blood groups in gastric bleeding. Gut (1966) 1.44
Hospital admissions for peptic ulcer during 1958-72. Br Med J (1976) 1.31
ABO blood group, secretor status and detection of Helicobacter pylori among patients with gastric or duodenal ulcers. Epidemiol Infect (1991) 1.30
Factors predisposing to recurrent haemorrhage after acute gastrointestinal bleeding. Br Med J (1971) 1.27
Epidemiology of venous thromboembolism. Ann Surg (1977) 1.19
Duodenal ulcers: early and late onset. Gut (1976) 1.15
Clinical data and characteristics differentiating types of peptic ulcer. Gut (1968) 1.14
ABO blood group and secretor status in stomal ulcer. Gut (1967) 1.10
Pre- and post-operative symptoms of patients with stomal ulcers. Gut (1967) 0.99
Secretor status and Helicobacter pylori infection are independent risk factors for gastroduodenal disease. Gut (1993) 0.90
Influence of the ABO blood groups and secretor status on bleeding and on perforation of duodenal ulcer. Gut (1968) 0.88
The value of investigations of the incidence of peptic ulcer in the families of patients with duodenal ulcer. J Med Genet (1972) 0.82
Genetics and gastroenterology. Gut (1971) 0.81
ABO blood groups and gastrointestinal function. Gut (1970) 0.80
Associations between hereditary blood factors and diseases. Bull World Health Organ (1973) 0.78
ABO blood type and arteriosclerosis obliterans. Am J Hum Genet (1972) 0.77
The medical treatment of gastric and duodenal ulcer. Postgrad Med J (1968) 0.76
The later clinical course of haematemesis. Postgrad Med J (1969) 0.75
Editorial: An ulcer in the family. Br Med J (1976) 0.75
Editorial: Genetics of duodenal ulcer. Br Med J (1975) 0.75
Influence of age and ABO blood groups in the precipitation of bleeding peptic ulcers. Gut (1969) 0.75
Clarifying the relationship between ABO/Rhesus blood group antigens and upper gastrointestinal bleeding. Dig Dis Sci (2008) 0.75
The blood groups in relation to peptic ulceration and carcinoma of colon, rectum, breast, and bronchus; an association between the ABO groups and peptic ulceration. Br Med J (1954) 15.70
ABO blood groups and secretor character in duodenal ulcer; population and sibship studies. Br Med J (1956) 6.35
The relationship of the ABO blood groups to duodenal and gastric ulceration. Br Med J (1955) 5.25
The histological distribution of blood group substances A and B in man. J Exp Med (1960) 3.79
The blood groups in peptic ulceration. Br Med J (1956) 3.41
The distribution of blood-group substances in human gastric and duodenal mucosa. Lancet (1957) 3.22
Secretion of blood group substances in duodenal, gastric and stomal ulcer, gastric carcinoma, and diabetes mellitus. Gut (1961) 2.43
THE PLASMA CONCENTRATION OF FACTOR VIII IN THE NORMAL POPULATION. II. THE EFFECTS OF AGE, SEX AND BLOOD GROUP. Br J Haematol (1964) 2.41
Observations on blood group distribution in peptic ulcer and gastric cancer. Gut (1960) 2.24
The secretor status in duodenal ulcer. Scott Med J (1958) 1.92
HEREDITARY ASPECTS OF DUODENAL ULCERATION: SERUM-PEPSINOGEN LEVEL IN RELATION TO ABO BLOOD GROUPS AND SALIVARY ABH SECRETOR STATUS. Br Med J (1964) 1.39
Secretion of ABH antigens in peptic ulceration and gastric carcinoma. Br Med J (1961) 1.27
Hereditary aspects of gastric secretory function; race and ABO blood groups in relationship to acid and pepsin production. Am J Med (1959) 1.15
The relationship between blood pepsin level, ABO blood group, and secretor status. Ann Intern Med (1962) 1.08
Response of patients with duodenal ulcer to augmented histamine test as related to blood groups and to secretor status. Gastroenterology (1962) 1.04
The risk of gastric cancer after medical treatment for gastric ulcer. Gastroenterologia (1957) 0.96
Correlation of blood groups with gastric acidity in normals. Indian J Med Sci (1960) 0.92
Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J (1976) 28.28
The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst (1981) 25.60
Observations on recent increase in mortality from asthma. Br Med J (1968) 14.82
A long-term follow-up study of women using different methods of contraception--an interim report. J Biosoc Sci (1976) 13.09
Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ (2000) 11.35
Investigation of relation between use of oral contraceptives and thromboembolic disease. Br Med J (1968) 9.17
Use of medicines in general practice. Br Med J (1977) 8.38
Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med (1997) 8.25
Mortality from smoking worldwide. Br Med Bull (1996) 7.87
Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. J Epidemiol Community Health (1978) 7.80
Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer (1975) 7.20
Investigation into use of drugs preceding death from asthma. Br Med J (1968) 6.76
Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet (2008) 6.67
Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies. BMJ (2004) 6.48
Review of company postmarketing surveillance studies. BMJ (1992) 6.21
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis. Br Med J (1965) 5.67
Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J (1979) 5.58
The circumstances preceding death from asthma in young people in 1968 to 1969. Br J Dis Chest (1971) 5.53
Mortality in relation to smoking: 22 years' observations on female British doctors. Br Med J (1980) 5.21
Frequency of eye complaints and rashes among patients receiving practolol and propranolol. Lancet (1977) 5.00
Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst (2004) 4.83
Mortality from lung cancer and other causes among workers in an asbestos textile factory. Br J Ind Med (1968) 4.81
The age distribution of cancer and a multi-stage theory of carcinogenesis. 1954. Int J Epidemiol (2004) 4.66
Mortality among doctors in different occupations. Br Med J (1977) 4.60
Investigation of relation between use of oral contraceptives and thromboembolic disease. A further report. Br Med J (1969) 4.50
Can dietary beta-carotene materially reduce human cancer rates? Nature (1981) 4.43
Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. Br Med J (Clin Res Ed) (1985) 4.30
100 years of observation on British radiologists: mortality from cancer and other causes 1897-1997. Br J Radiol (2001) 4.25
Risk of lung cancer associated with residential radon exposure in south-west England: a case-control study. Br J Cancer (1998) 4.24
Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri. Br J Cancer (1980) 4.11
Mortality of British doctors in relation to smoking: observations on coronary thrombosis. Natl Cancer Inst Monogr (1966) 3.92
Uses of barium meal examination in dyspeptic patients under 50. Br Med J (1977) 3.82
Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br J Cancer (1987) 3.69
Immunosurveillance and cancer: epidemiological evidence. Br Med J (1970) 3.68
Treatment of gastric ulcer with carbenoxolone: antagonistic effect of spironolactone. Gut (1968) 3.46
Towards estimation and confidence intervals. Br Med J (Clin Res Ed) (1986) 3.22
What are the effects of the fifth revision of the Declaration of Helsinki? BMJ (2001) 3.17
Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial. BMJ (1992) 3.17
A mathematical model for the age distribution of cancer in man. Int J Cancer (1969) 3.08
20 years of hospital admissions for peptic ulcer in England and Wales. Lancet (1981) 3.06
Trends in mortality among British doctors in relation to their smoking habits. J R Coll Physicians Lond (1972) 2.99
Changing patterns in epidemiology of Crohn's disease. Lancet (1974) 2.99
Postmarketing surveillance of the safety of cimetidine: 12 month mortality report. Br Med J (Clin Res Ed) (1983) 2.90
Oral contraceptives and breast neoplasia: a retrospective study. Br Med J (1972) 2.81
Summarizing indices for comparison of cancer incidence data. Int J Cancer (1967) 2.80
Trends in mortality from cancer of the uterus in Canada and in England and Wales. Br J Prev Soc Med (1973) 2.80
Effect of different operation policies on mortality from bleeding peptic ulcer. Lancet (1979) 2.74
Prospects for prevention. Br Med J (Clin Res Ed) (1983) 2.68
Cancers of the lung and nasal sinuses in nickel workers. Br J Cancer (1970) 2.67
Case-control study of the husbands of women with dysplasia or carcinoma of the cervix uteri. Lancet (1981) 2.63
Bladder cancer mortality in England and Wales in relation to cigarette smoking and saccharin consumption. Br J Prev Soc Med (1974) 2.60
Outcome of pregnancy in women using an intrauterine device. Lancet (1974) 2.58
A summary of mortality and incidence of cancer in men from the United Kingdom who participated in the United Kingdom's atmospheric nuclear weapon tests and experimental programmes. Br Med J (Clin Res Ed) (1988) 2.57
Aspirin, paracetamol, and haematemesis and melaena. Gut (1982) 2.55
Epidemiological evidence for the association of aspirin and acute gastrointestinal bleeding. Gut (1970) 2.55
Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study. Scand J Gastroenterol (1987) 2.54
Double-blind trial of linoleate supplementation of the diet in multiple sclerosis. Br Med J (1973) 2.53
The geographical distribution of cancer. Br J Cancer (1969) 2.53
Geographical variation in mortality from leukaemia and other cancers in England and Wales in relation to proximity to nuclear installations, 1969-78. Br J Cancer (1989) 2.50
Minor tranquillisers and road accidents. Br Med J (1979) 2.50
Oral contraceptives and breast cancer. Progress report of an epidemiological study. Lancet (1975) 2.46
Mortality among patients with ankylosing spondylitis after a single treatment course with x rays. Br Med J (Clin Res Ed) (1982) 2.46
Mortality from cancer of the cervix uteri in British Columbia and other parts of Canada. Br J Prev Soc Med (1968) 2.44
Cimetidine and gastric cancer: preliminary report from post-marketing surveillance study. Br Med J (Clin Res Ed) (1982) 2.40
A survey of doctors' attitudes to smoking. Br J Prev Soc Med (1969) 2.39
An epidemiological perspective of the biology of cancer. Cancer Res (1978) 2.39
Record linkage for drug monitoring. J Epidemiol Community Health (1981) 2.36
Trends in tar, nicotine, and carbon monoxide yields of UK cigarettes manufactured since 1934. Br Med J (Clin Res Ed) (1981) 2.35
Early oral contraceptive use and breast cancer: results of another case-control study. Br J Cancer (1987) 2.35
Cancer near potential sites of nuclear installations. Lancet (1989) 2.33
Mortality of gasworkers - final report of a prospective study. Br J Ind Med (1972) 2.31
Cancer risks in a historical UK cohort of benzene exposed workers. Occup Environ Med (2005) 2.30
Retrospective study of the association between use of rauwolfia derivatives and breast cancer in English women. Lancet (1974) 2.29
Rights involve responsibilities for patients. BMJ (2001) 2.28
Fallout, radiation doses near Dounreay, and childhood leukaemia. Br Med J (Clin Res Ed) (1987) 2.23
The case for recording events in clinical trials. Br Med J (1977) 2.23
Sugar consumption and cigarette smoking. Lancet (1970) 2.22
Smoking and Crohn's disease. Br Med J (Clin Res Ed) (1984) 2.17
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
Oral contraceptives and breast cancer. Lancet (1983) 2.16
Nitrates, nitrites and gastric cancer in Great Britain. Nature (1985) 2.15
Consequences for research if use of anonymised patient data breaches confidentiality. BMJ (1999) 2.12
Mortality experience of male workers at a UK tin smelter. Occup Med (Lond) (2005) 2.10
Gastric and duodenal ulcer and their associated diseases. Lancet (1976) 2.10
A century of asthma deaths in young people. Br Med J (1968) 2.09
Cimetidine and ranitidine: comparison of effects on hepatic drug metabolism. Br Med J (1980) 2.09
Cancers of the lung and nasal sinuses in nickel workers: a reassessment of the period of risk. Br J Ind Med (1977) 2.09
Post-marketing surveillance of the safety of cimetidine: twelve-month morbidity report. Q J Med (1985) 2.07
Smoking and ulcerative colitis. Br Med J (Clin Res Ed) (1984) 2.05
Postoperative thromboembolism and the use of oral contraceptives. Br Med J (1970) 2.04
Cigarette smoking and inflammatory bowel disease. Gastroenterology (1987) 2.04
Risk factors for myocardial infarction in young women. Br J Prev Soc Med (1976) 2.01
Aspirin and bleeding peptic ulcers in the elderly. BMJ (1988) 2.00
Cancer near nuclear installations. Nature (1987) 1.98
Nuffield Lecture. Monitoring the National Health Service. Proc R Soc Med (1973) 1.97
Impact of computerized quality of life screening on physician behaviour and patient satisfaction in lung cancer outpatients. Psychooncology (2000) 1.94
Mortality among patients with ankylosing spondylitis not given X-ray therapy. N Engl J Med (1977) 1.94